PPIL2 is a target of the JAK2/STAT5 pathway and promotes myeloproliferation via degradation of p53

Pan Wang(Northwestern University), Peng Ji(Robert H. Lurie Comprehensive Cancer Center of Northwestern University)
Journal of Clinical Investigation
May 8, 2025
Cited by 1


Related Papers